pidnarulex
Showing 1 - 1 of 1
Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial (Pidnarulex, Talazoparib)
Not yet recruiting
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Pidnarulex
- Talazoparib
- (no location specified)
Jun 15, 2022